Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Cancer mortality rates vary among major Hispanic ethnic groups

Cancer mortality rates vary among major Hispanic ethnic groups

Study provides insight into how microRNA may amplify effects of drug treatment in liver cancer

Study provides insight into how microRNA may amplify effects of drug treatment in liver cancer

SLU scientists receive $416,000 NIH grant to advance research on hepatitis B cure

SLU scientists receive $416,000 NIH grant to advance research on hepatitis B cure

New analysis reveals low incidence of liver cancer in patients with cirrhosis

New analysis reveals low incidence of liver cancer in patients with cirrhosis

Caspase-2 enzyme deficiency linked to higher cancer risk

Caspase-2 enzyme deficiency linked to higher cancer risk

Quest Diagnostics introduces new HBV test service to help evaluate patient’s response to drug therapies

Quest Diagnostics introduces new HBV test service to help evaluate patient’s response to drug therapies

Scientists generate new index to accurately predict presence of fatty liver disease

Scientists generate new index to accurately predict presence of fatty liver disease

A test to evaluate Hepatitis B therapy launched by Quest Diagnostics

A test to evaluate Hepatitis B therapy launched by Quest Diagnostics

MGH-developed CTC-iChip with digital PCR assay improves detection of early-stage liver cancer

MGH-developed CTC-iChip with digital PCR assay improves detection of early-stage liver cancer

Study provides insights into CPEB4 gene and fatty liver disease

Study provides insights into CPEB4 gene and fatty liver disease

New report reveals 25% drop in overall cancer death rate in the U.S.

New report reveals 25% drop in overall cancer death rate in the U.S.

Natural antioxidant can protect offspring of obese mice from NAFLD, study shows

Natural antioxidant can protect offspring of obese mice from NAFLD, study shows

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Combination of diabetes and hypertension drugs can effectively treat cancer

Combination of diabetes and hypertension drugs can effectively treat cancer

Scientists unravel novel role of signalling protein in common type of liver cancer

Scientists unravel novel role of signalling protein in common type of liver cancer

Scientists unveil role of NOX4 protein as inhibitor of invasion and metastasis of liver tumor cells

Scientists unveil role of NOX4 protein as inhibitor of invasion and metastasis of liver tumor cells

Researchers discover new pathway that opens door to treat non-alcoholic fatty liver disease

Researchers discover new pathway that opens door to treat non-alcoholic fatty liver disease

NASPGHAN clinical practice guidelines recommend screening test for NAFLD in obese children

NASPGHAN clinical practice guidelines recommend screening test for NAFLD in obese children

New green nanotechnology approach targets, destroys precancerous tumor cells in livers of mice

New green nanotechnology approach targets, destroys precancerous tumor cells in livers of mice

Research provides insight into molecular mechanisms involved in immune response to HBV

Research provides insight into molecular mechanisms involved in immune response to HBV